1. Home
  2. MAGN vs PTHL Comparison

MAGN vs PTHL Comparison

Compare MAGN & PTHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MAGN
  • PTHL
  • Stock Information
  • Founded
  • MAGN 1864
  • PTHL 1998
  • Country
  • MAGN United States
  • PTHL China
  • Employees
  • MAGN N/A
  • PTHL N/A
  • Industry
  • MAGN Paper
  • PTHL
  • Sector
  • MAGN Basic Materials
  • PTHL
  • Exchange
  • MAGN Nasdaq
  • PTHL Nasdaq
  • Market Cap
  • MAGN 67.4M
  • PTHL 65.0M
  • IPO Year
  • MAGN N/A
  • PTHL 2024
  • Fundamental
  • Price
  • MAGN $17.21
  • PTHL $4.25
  • Analyst Decision
  • MAGN
  • PTHL
  • Analyst Count
  • MAGN 0
  • PTHL 0
  • Target Price
  • MAGN N/A
  • PTHL N/A
  • AVG Volume (30 Days)
  • MAGN 1.2M
  • PTHL 148.5K
  • Earning Date
  • MAGN 01-01-0001
  • PTHL 11-26-2024
  • Dividend Yield
  • MAGN N/A
  • PTHL N/A
  • EPS Growth
  • MAGN N/A
  • PTHL N/A
  • EPS
  • MAGN N/A
  • PTHL N/A
  • Revenue
  • MAGN $2,175,000,000.00
  • PTHL $572,291.00
  • Revenue This Year
  • MAGN N/A
  • PTHL N/A
  • Revenue Next Year
  • MAGN N/A
  • PTHL N/A
  • P/E Ratio
  • MAGN $68.89
  • PTHL N/A
  • Revenue Growth
  • MAGN N/A
  • PTHL 2.32
  • 52 Week Low
  • MAGN $15.86
  • PTHL $3.32
  • 52 Week High
  • MAGN $35.23
  • PTHL $6.45
  • Technical
  • Relative Strength Index (RSI)
  • MAGN N/A
  • PTHL N/A
  • Support Level
  • MAGN N/A
  • PTHL N/A
  • Resistance Level
  • MAGN N/A
  • PTHL N/A
  • Average True Range (ATR)
  • MAGN 0.00
  • PTHL 0.00
  • MACD
  • MAGN 0.00
  • PTHL 0.00
  • Stochastic Oscillator
  • MAGN 0.00
  • PTHL 0.00

About PTHL Pheton Holdings Ltd Class A Ordinary Shares

Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy. FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.

Share on Social Networks: